
GLP-1 boom in China, India, Brazil could create $22bn market by 2035, J.P. Morgan says
The combined China-India-Brazil market for weight-loss drugs could grow to $22 billion by 2035 from $6.6 billion currently, J.P. Morgan estimated, as improving affordability and broader access drive adoption in largely untapped patient populations.



























_20251003092603298_af0c50_20251010094012153_327c07.webp)















.jpg)








































_20261014054828896_5c1abf.webp)
_20260119073230672_ad4bfd_20260316121911953_d5e9bd_20260617052528905_cb091b%20(2)_20261016125331743_497413.webp)


